
Quest Laboratories Ltd is Rated Buy by MarketsMOJO
2026-04-05 10:10:21Quest Laboratories Ltd is rated 'Buy' by MarketsMOJO. This rating was last updated on 30 March 2026, reflecting a recalibration of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 April 2026, providing investors with the latest perspective on the company’s position.
Read full news article
Quest Laboratories Ltd is Rated Buy by MarketsMOJO
2026-03-24 10:10:29Quest Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 17 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
Quest Laboratories Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-03-16 15:00:13Quest Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 16 Mar 2026, hitting its lower circuit limit with a maximum daily loss of 5.0%. The stock closed at ₹106.4, down ₹5.6 from the previous close, reflecting intense selling pressure and panic among investors despite the broader market’s positive momentum.
Read full news article
Quest Laboratories Ltd is Rated Strong Buy
2026-03-13 10:10:29Quest Laboratories Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 12 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
Quest Laboratories Ltd Hits Upper Circuit Amid Strong Buying Pressure
2026-03-13 10:00:31Quest Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit price limit on 13 Mar 2026, reflecting robust buying interest and a maximum daily gain of 5.0%. This price action underscores heightened investor enthusiasm despite a backdrop of subdued sector and benchmark indices.
Read full news article
Quest Laboratories Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-03-04 13:00:11Quest Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 4 Mar 2026, hitting its lower circuit limit with a maximum daily loss of 4.97%. The stock closed at ₹109.05, down ₹5.7 from the previous close, reflecting intense selling pressure and panic among investors.
Read full news article
Quest Laboratories Ltd is Rated Strong Buy
2026-03-02 10:10:36Quest Laboratories Ltd is rated Strong Buy by MarketsMOJO. This rating was last updated on 16 Feb 2026, reflecting a positive reassessment of the stock’s potential. However, all fundamentals, returns, and financial metrics discussed below are current as of 02 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Quest Laboratories Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-02-27 11:00:09Quest Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 27 Feb 2026, hitting its lower circuit price limit as panic selling gripped the stock. The share price plunged by 4.99%, underperforming both its sector and the broader Sensex, reflecting intense selling pressure and unfilled supply in the market.
Read full news article
Quest Laboratories Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure
2026-02-26 15:00:08Quest Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 26 Feb 2026, hitting its lower circuit limit amid intense selling pressure. The stock closed at ₹126.25, down 4.97% on the day, underperforming both its sector and the broader market as panic selling gripped investors.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






